Evidence of a substantial decline in prevalence of HIV-1 infection among pregnant women: Data from 1995 to 2003 in Dar es Salaam,Tanzania

Abstract

Objective: To determine the prevalence trends of HIV-1 infection among pregnant women seen between 1995 and 2003 at public antenatal clinics (ANC) in the city of Dar es Salaam. Design and settings: Cross-sectional studies among pregnant women at selected antenatal clinics who were offered HIV testing as part of research and service programmes to prevent vertical transmission of HIV infection and improve pregnancy outcomes. Subjects and methods: Consenting women gave blood for HIV antibody testing using a sequential ELISA protocol. Sociodemographic information was collected using structured interviews. Results: In total, 62% of women attending the antenatal clinics gave informed consent for HIV testing and 51,076 had final confirmed results available for this analysis. Women below 20 years of age had the lowest HIV seroprevalence. The HIV-1 prevalence declined from 14.2% in 1995 to 10.6% in 2003. Conclusion: There is a definite substantial decline in prevalence of HIV-1 infection among pregnant women in Dar es Salaam following ongoing interventions, which have been carried out in Tanzania. There is a need to further strengthen these interventions.

Keywords

Africa ANC decline HIV infection seroprevalence

Get full access to this article

View all access options for this article.

References

Unaids/Who. AIDS epidemic update December 2004. Joint United Nations Programme on HIV/AIDS (UNAIDS) . Geneva: World Health Organisation ; 2005.

Gunnar H. , Shao J. , Mhalu F. , et al. The AIDS epidemic in Tanzania: Rate of spread of HIV in blood donors and pregnant women in Dar es Salaam. Scand J Infect Dis 1992;24:701—6.

Mwakagile D. , Swai A. , Sandstrom E. , et al. High frequency of sexuality transmitted diseases among pregnant women in Dar es Salaam, Tanzania: Need for intervention . East Afr Med J 1996 ;73:675—8.

Petry K. , Kingu H. HIV infection among pregnant women in Lindi, Tanzania, 1989—1993 . Intern STD/AIDS 1996;7:265—8.

Mbulaiteye S. , Mahe C. , Whitworth J. , et al. Declining HIV-1 incidence and associated prevalence over 10 years in rural population in South-west Uganda: a cohort study. Lancet 2002;360:41—6.

Asamoah-Odei E. , Calleja J. , Boerma J. HIV prevalence and trends in sub-Saharan Africa: No decline and large sub regional differences. Lancet 2004;364:35—40.

Tsegaye A. , Rinke de Wit T. , Mekonnen Y. , et al. Decline in prevalence of HIV-1 infection and syphilis among young women attending antenatal care clinics in Addis Ababa, Ethiopia: Results from sentinel surveillance, 1995—2001. J Acquir Immune Defic Syndr 2002;30:359—62.

Kwesigabo G. , Killewo J. , Urassa W. , et al. Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years' experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr 2000;23:410—17.

Kwesigabo G. , Killewo J. , Godoy C. , et al. Decline in the prevalence of HIV-1 infection in young women in the Kagera region of Tanzania . J Acquir Immune Defic Syndr Human Retrovirol 1998;17:262—8.

10.

Kwesigabo G. Trends of HIV infection in the Kagera region of Tanzania 1987—2000. Umea University Medical Dissertations New Series No 710, Umea, Sweden: Umea University ; 2001 .

11.

Lugalla J. , Emmelin M. , Mutembei A. , et al. Social cultural and sexual behavioural determinants of observed decline of HIV infection trends: Lessons from Kagera region, Tanzania. Soc Sci Med 2004;59:185—98.

12.

Fawzi W. , Msamanga G. , Spiegelman D. , et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351:1477—82.

13.

Fawzi WW , Villamor E. , Msamanga GI , et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania . Am J Clin Nutr 2005;81:161—7.

14.

Urassa W. , Bredberg-Raden U. , Mbena E. , et al. Alternative confirmatory strategies in HIV-1 antibody testing. J Acquir Immune Defic Syndr 1992;5:170—6.

15.

Urassa W. , Matunda S. , Bredberg Raden U , et al. Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection. Clin Diagn Virol 1994;2:1—6.

16.

WHO Proposed criteria for interpretation of results from Western Blot for HIV-1, HIV-2, HTLV-1, and HTLV-II. Wkly Epidemiol Rec 1990;39:281—3.

17.

Anderson R. , Rosenberg H. Age standardization of death rates: Implementation of the year 2000 standard. Natl Vital Stat Rep 1998;47:1—16.

18.

Agresti A. , Coull B. Approximate is better than ``exact'' for interval estimation of binomial proportions. Am Sta 1998; 52:119—26.

19.

Kigadye R. , Klokke A. , Nicoll A. , et al. Sentinel surveillance for HIV-1 among pregnant women in developing country: 3 years' experience and comparison with a population serosurvey. AIDS 1993;7:949—55.

20.

Kwesigabo G. , Killewo J. , Sandstrom A. Sentinel surveillance and cross-sectional survey on HIV infection prevalence: A comparative study . East Afr Med J 1996;73:298—302.

21.

Zaba B. , Boerma J. , White R. Monitoring the AIDS epidemic using HIV prevalence among young women attending antenatal clinics: Prospects and problems. AIDS 2000;14: 1633—45.

22.

Kilian A. , Gregson S. , Ndyanabangi B. , et al. Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda. AIDS 1999;13: 391—8.

23.

Klepp K. , Mdeki S. , Leshabari M. , et al. AIDS education in Tanzania: Promoting risk reduction among primary school children. Am J Public Health 1997;87:1931—6.

24.

Urban M. , Chersich M. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care . S Afr Med J 2000;94:362—6.